Compare Indospring Tbk. (INDS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indospring Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indospring Tbk. trades at Rp260 (market cap 1.78T, 2.53M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indospring Tbk. is far larger — about 17× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INDS | SCPI | |
|---|---|---|
Market Cap | 1.78T | 104.4B |
Volume | 2.53M | — |
Lot | 25.35K | — |
Turnover | 664.36M | — |
Average Price | 262.12 | — |
Value | 664.36M | — |
Indicative Equilibrium Price | 260 | — |
Indicative Equilibrium Volume | 2.49K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indospring Tbk.
PT Indospring started its operations in 1978 producing motor vehicles, railway rolling stocks and industrial machinery. The company has an technical assistance agreement with Mitsubishi Steel Manufacturing Co., And recently the products are also exported.
Read more on INDS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
